Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)

Assets	$2.57M
Expense Ratio	0.98%
PE Ratio	n/a
Shares Out	75,001
Dividend (ttm)	$0.62
Dividend Yield	1.89%
Ex-Dividend Date	Jun 23, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	1,337
Open	33.46
Previous Close	34.31
Day's Range	32.98 - 33.53
52-Week Low	25.71
52-Week High	38.89
Beta	n/a
Holdings	11
Inception Date	Oct 1, 2025

About TBXU

Fund Home Page

The Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: TBXU
• ETF Provider: Direxion
• Index Tracked: NYSE Biotechnology Top 5 Equal Weight Index

Top 10 Holdings

Name	Symbol	Weight
Goldman Finl Sq Trsry Inst 506	n/a	29.08%
Regeneron Pharmaceuticals, Inc.	REGN	11.37%
Amgen Inc.	AMGN	10.97%
Vertex Pharmaceuticals Incorporated	VRTX	10.90%
Gilead Sciences, Inc.	GILD	10.60%
argenx SE	ARGX	9.90%
Dx D Biotech T 5 Bull 2x Etf Swap	n/a	6.49%
Goldman Sachs Fin Gov 465 Institut	n/a	6.17%
Dx D Biotech T 5 Bull 2x Etf Swap	n/a	2.87%
Dreyfus Govt Cash Man Ins	n/a	1.65%

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 23, 2026	$0.11101	Jun 30, 2026
Mar 24, 2026	$0.09893	Mar 31, 2026
Dec 23, 2025	$0.10111	Dec 31, 2025
Dec 10, 2025	$0.31143	Dec 17, 2025

Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Aug 4, 2026

Data Sources Report a data error